The local-regionally advanced nasopharyngeal carcinoma jigsaw puzzle: Where does the chemotherapy piece fit?

Journal of Clinical Oncology

Volumn 20, Issue 8, 2002, Pages 1968-1970

  Rischin, Danny ^a   Peters, Lester J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; EDITORIAL; HUMAN; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0037089677     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.8.1968     Document Type: Editorial

References (20)

1. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
2. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer
3. Effects of concomitant cisplatin and radiotherapy on inoperable non- small-cell lung cancer
4. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data: MACH-NC Collaborative Group - Meta-analysis of chemotherapy on head and neck cancer
5. Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil
6. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy
7. Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma
8. Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation
9. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
10. Superiority of 5-year survival with chemoradiotherapy vs radiotherapy in patients with locally advanced nasopharyngeal cancer. Intergroup 0099 Phase III study: Final report
11. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (> or = N2, MO) undifferentiated nasopharyngeal carcinoma: A positive effect on progression-free survival - VUMCA I trial
12. Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma
13. Combined chemo/radiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: Results of a meta-analysis of 1528 patients from 6 randomised trials
14. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal carcinoma: Asian-Oceanian Clinical Oncology Association Nasopharynx Cancer Study Group
15. Adjuvant chemotherapy with vincristine, cyclophosphamide, and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer: Results of a 4-year multicenter randomized study
16. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression free survival analysis of a phase III randomized trial
17. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival
18. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional control
19. Preliminary report on a randomised controlled trial of concomitant UFT/radiation and adjuvant chemotherapy for loco-regionally advanced non-metastatic nasopharyngeal carcinoma
20. J Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: Toxicities and preliminary results